Esperion Therapeutics, Inc. (ESPR)
NASDAQ: ESPR · Real-Time Price · USD
2.480
+0.070 (2.90%)
Nov 21, 2024, 1:34 PM EST - Market open
Esperion Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 144.72 | 82.25 | 124.78 | 208.89 | 304.96 | 166.13 | Upgrade
|
Short-Term Investments | - | - | 42.09 | 50.44 | - | 34.65 | Upgrade
|
Cash & Short-Term Investments | 144.72 | 82.25 | 166.86 | 259.33 | 304.96 | 200.78 | Upgrade
|
Cash Growth | 26.02% | -50.71% | -35.66% | -14.96% | 51.89% | 47.61% | Upgrade
|
Receivables | 67.82 | 48.49 | 33.73 | 22.93 | 12.39 | - | Upgrade
|
Inventory | 80.1 | 65.62 | 35.2 | 34.39 | 16.14 | - | Upgrade
|
Prepaid Expenses | 14.91 | 4.7 | 10.89 | 12.31 | 12.41 | 10.01 | Upgrade
|
Restricted Cash | - | - | - | - | - | 0.93 | Upgrade
|
Total Current Assets | 307.56 | 201.07 | 246.68 | 328.97 | 345.9 | 211.71 | Upgrade
|
Property, Plant & Equipment | 6.5 | 4.68 | 1.2 | 2.56 | 7.31 | 2.68 | Upgrade
|
Other Intangible Assets | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | Upgrade
|
Other Long-Term Assets | - | - | - | 50 | - | - | Upgrade
|
Total Assets | 314.11 | 205.8 | 247.94 | 381.59 | 353.26 | 214.45 | Upgrade
|
Accounts Payable | 34.86 | 31.72 | 23.04 | 17.56 | 51.98 | 28.86 | Upgrade
|
Accrued Expenses | 22.79 | 28.44 | 18.63 | 21.23 | 27.43 | 29.38 | Upgrade
|
Current Portion of Long-Term Debt | - | 34.83 | 24.76 | 11.3 | 5.39 | 5.24 | Upgrade
|
Current Portion of Leases | 2.74 | 1.55 | 0.38 | 1.39 | 2.59 | 0.45 | Upgrade
|
Current Unearned Revenue | 15.08 | 25.4 | 3.51 | 5.68 | 1.66 | 2.15 | Upgrade
|
Other Current Liabilities | 90.4 | 34.28 | 21.99 | 16.19 | 5.03 | - | Upgrade
|
Total Current Liabilities | 165.87 | 156.22 | 92.31 | 73.35 | 94.07 | 66.08 | Upgrade
|
Long-Term Debt | 262.92 | 501.55 | 478.74 | 504.02 | 350.58 | 127.31 | Upgrade
|
Long-Term Leases | 3.3 | 3.02 | 0.67 | 0.52 | 3.45 | 1.11 | Upgrade
|
Long-Term Unearned Revenue | - | - | - | 0.63 | - | - | Upgrade
|
Other Long-Term Liabilities | 252.23 | - | - | - | 1.29 | - | Upgrade
|
Total Liabilities | 684.32 | 660.79 | 571.72 | 578.53 | 449.39 | 194.5 | Upgrade
|
Common Stock | 0.2 | 0.12 | 0.08 | 0.06 | 0.03 | 0.03 | Upgrade
|
Additional Paid-In Capital | 1,264 | 1,149 | 1,071 | 964.4 | 797.66 | 715.17 | Upgrade
|
Retained Earnings | -1,580 | -1,549 | -1,340 | -1,106 | -838.82 | -695.27 | Upgrade
|
Treasury Stock | -55 | -55 | -55 | -55 | -55 | - | Upgrade
|
Comprehensive Income & Other | - | - | -0 | -0.03 | - | 0.02 | Upgrade
|
Shareholders' Equity | -370.21 | -454.99 | -323.78 | -196.94 | -96.13 | 19.95 | Upgrade
|
Total Liabilities & Equity | 314.11 | 205.8 | 247.94 | 381.59 | 353.26 | 214.45 | Upgrade
|
Total Debt | 268.96 | 540.95 | 504.55 | 517.24 | 362.01 | 134.11 | Upgrade
|
Net Cash (Debt) | -124.25 | -458.7 | -337.69 | -257.9 | -57.05 | 66.67 | Upgrade
|
Net Cash Growth | - | - | - | - | - | -50.98% | Upgrade
|
Net Cash Per Share | -0.75 | -4.45 | -5.09 | -8.92 | -2.08 | 2.46 | Upgrade
|
Filing Date Shares Outstanding | 197.04 | 185.05 | 76.57 | 62.82 | 27.94 | 27.51 | Upgrade
|
Total Common Shares Outstanding | 195.44 | 118.21 | 74.57 | 60.88 | 25.92 | 27.5 | Upgrade
|
Working Capital | 141.68 | 44.84 | 154.38 | 255.62 | 251.83 | 145.63 | Upgrade
|
Book Value Per Share | -1.89 | -3.85 | -4.34 | -3.23 | -3.71 | 0.73 | Upgrade
|
Tangible Book Value | -370.27 | -455.05 | -323.83 | -197 | -96.19 | 19.89 | Upgrade
|
Tangible Book Value Per Share | -1.89 | -3.85 | -4.34 | -3.24 | -3.71 | 0.72 | Upgrade
|
Machinery | - | 0.86 | 1.45 | 1.45 | 1.45 | 1.16 | Upgrade
|
Construction In Progress | - | - | - | - | - | 0.1 | Upgrade
|
Leasehold Improvements | - | 0.19 | 0.3 | 0.3 | 0.3 | 0.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.